Voruciclib,1000023-04-0

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Voruciclib

CAS No. : 1000023-04-0

MCE 国际站：Voruciclib

产品活性：Voruciclib 是一种具有口服活性和选择性 CDK 抑制剂，K_i 为 0.626 nM-9.1 nM。Voruciclib 可以有效阻断 MCL-1 的转录调节子 CDK9。Voruciclib 抑制多种弥漫性大 B 细胞淋巴瘤 (DLBCL) 模型中 MCL-1 的表达。

研究领域：Cell Cycle/DNA Damage

作用靶点：CDK

In Vitro: Voruciclib (0.5-5 µM; 6 hours) shows targeted downregulation of MCL-1 in both ABC and GCB subtypes.
K_i values for each target such as CDK9/cyc T2, CDK9/cyc T1, CDK6/cyc D1, CDK4/cyc D1, CDK1/cyc B, and CDK1/cyc A for Voruciclib hydrochloride are 0.626 nM, 1.68 nM, 2.92 nM, 3.96 nM, 5.4 nM, 9.1 nM, respectively.

In Vivo: Combination of Voruciclib hydrochloride (200 mpk; Oral gavage) and Venetoclax (10 mpk, 1 mpk, 50 mpk, 25 mpk in U2932, RIVA, SU-DHL-4 and NU-DHL-1, respectively) leads to enhance tumor growth inhibition compared to either drug alone in U2932, RIVA, SU-DHL-4 (six days per week for 4 weeks), and NU-DHL-1 models (five days per week for 3 weeks) of DLBCL.

相关产品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Palbociclib  |  Abemaciclib  |  Ro-3306  |  Ribociclib  |  Dinaciclib  |  GSK3326595  |  THZ1  |  Flavopiridol  |  SR-4835  |  (R)-Roscovitine  |  THZ531  |  AZD4573  |  SY-5609  |  Kenpaullone  |  Wogonin  |  SNS-032  |  GSK 3 Inhibitor IX  |  Cirtuvivint  |  NVP-2  |  Toyocamycin  |  Fadraciclib  |  Simurosertib  |  AT7519  |  OTS964 hydrochloride  |  JNJ-7706621  |  KB-0742 dihydrochloride  |  BSJ-4-116

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds